Every record from Janoshik · page 2
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041328 | Semaglutide | WWB | WWB-2606-N3192 | 2026-Q3 | 99.48 | 4.59 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041333 | Semaglutide | WWB | WWB-2606-N3192 | 2026-Q3 | 98.80 | 4.51 | 90.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043406 | Semaglutide | WXT | WXT-2604-C4728 | 2026-Q3 | 97.24 | 4.65 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043090 | Ipamorelin | KP | KP-2606-D5887 | 2026-Q3 | 98.18 | 3.07 | 101.2 | Laboratory-retained | 1 | FAIL |
| AX-2026-043421 | Sermorelin | WXT | WXT-2608-P4867 | 2026-Q3 | 98.15 | 3.09 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043336 | Liraglutide | CPC | CPC-2602-G1978 | 2026-Q3 | 97.69 | 4.58 | 104.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043322 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.79 | 4.88 | 96.1 | Supplier-supplied | 2 | FAIL |
| AX-2026-043028 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 96.52 | 6.09 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042662 | CJC-1295 (no DAC) | GGPeps | GGPE-2606-E8495 | 2026-Q3 | 97.89 | 4.11 | 95.1 | Supplier-supplied | 0 | FAIL |
| AX-2026-042399 | Semaglutide | SWB | SWB-2602-X5278 | 2026-Q3 | 98.56 | 3.82 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041536 | Retatrutide | QYB | QYB-2602-G6308 | 2026-Q3 | 98.05 | 2.92 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041483 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | 2026-Q3 | 99.93 | 3.87 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041921 | TB-500 | JEEP | JEEP-2605-M4874 | 2026-Q3 | 99.90 | 1.76 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042542 | Tesamorelin | ERP | ERP-2604-W7280 | 2026-Q3 | 98.54 | 4.58 | 103.1 | Supplier-supplied | 2 | FAIL |
| AX-2026-041922 | TB-500 | JEEP | JEEP-2605-M4874 | 2026-Q3 | 99.41 | 2.60 | 95.7 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041772 | Semaglutide | FGP | FGP-2602-M1508 | 2026-Q3 | 99.79 | 3.03 | 107.5 | Supplier-supplied | 0 | PASS |
| AX-2026-041425 | Ipamorelin | QYB | QYB-2605-H4298 | 2026-Q3 | 99.93 | 3.65 | 93.4 | Supplier-supplied | 0 | PASS |
| AX-2026-041973 | Humanin (HNG) | TFC | TFC-2605-U5564 | 2026-Q3 | 99.62 | 7.03 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-041769 | Semaglutide | FGP | FGP-2602-M1508 | 2026-Q3 | 99.13 | 2.55 | 92.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043178 | Kisspeptin-10 | GL Biochem | GLBI-2608-N8085 | 2026-Q3 | 98.24 | 4.44 | 96.0 | Supplier-supplied | 2 | FAIL |
| AX-2026-043112 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 98.85 | 5.68 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043110 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 99.58 | 5.91 | 104.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041928 | TB-500 | JEEP | JEEP-2605-M4874 | 2026-Q3 | 99.88 | 1.84 | 92.8 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041686 | CJC-1295 (no DAC) | QSC | QSC-2606-V8637 | 2026-Q3 | 99.93 | 4.04 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043323 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 97.19 | 5.43 | 95.3 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042666 | CJC-1295 (no DAC) | GGPeps | GGPE-2606-E8495 | 2026-Q3 | 97.87 | 3.74 | 94.3 | Buyer-sourced | 2 | FAIL |
| AX-2026-042167 | Semaglutide | Homopeptide | HOMO-2604-X8921 | 2026-Q3 | 99.57 | 5.06 | 104.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041980 | Humanin (HNG) | TFC | TFC-2605-U5564 | 2026-Q3 | 99.90 | 7.01 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043423 | Sermorelin | WXT | WXT-2608-P4867 | 2026-Q3 | 98.28 | 3.86 | 98.5 | Buyer-sourced | 0 | PASS |
| AX-2026-043315 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.55 | 5.34 | 96.5 | Supplier-supplied | 2 | FAIL |
| AX-2026-042276 | SLU-PP-332 | Homopeptide | HOMO-2602-Y2822 | 2026-Q3 | 99.58 | 4.95 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041273 | Liraglutide | WWB | WWB-2607-X2189 | 2026-Q3 | 99.87 | 4.27 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041272 | Liraglutide | WWB | WWB-2607-X2189 | 2026-Q3 | 99.15 | 4.12 | 97.2 | Supplier-supplied | 0 | PASS |
| AX-2026-043330 | Liraglutide | CPC | CPC-2602-G1978 | 2026-Q3 | 97.90 | 4.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042279 | SLU-PP-332 | Homopeptide | HOMO-2602-Y2822 | 2026-Q3 | 99.27 | 4.62 | 90.9 | Supplier-supplied | 0 | PASS |
| AX-2026-041388 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.59 | 4.24 | 105.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043504 | BPC-157 | BCH | BCH-2603-G6422 | 2026-Q3 | 98.38 | 4.45 | 95.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042741 | Selank | GGPeps | GGPE-2603-J9708 | 2026-Q3 | 99.15 | 9.12 | 92.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042482 | Melanotan II | SWB | SWB-2603-A5707 | 2026-Q3 | 99.22 | 4.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042462 | Kisspeptin-10 | SWB | SWB-2603-D6238 | 2026-Q3 | 98.61 | 4.73 | 96.5 | Supplier-supplied | 3 | MARGINAL |